Choice Institutional Equities's report on Mahindra Lifespace Developers
MAHLIFE recorded healthy growth on a YOY basis; pre-sales and collections increased by 71.3% and 5.5%, respectively. While Average Selling Price also grew significantly by 28.4% YoY. Mahindra Blossom (Hopefarm, Bengaluru) witnessed exceptional traction with INR 10 Bn sales in a single weekend (to be recognised in Q4FY26). While Bhandup and Mahalaxmi projects are nearing final approval, new launches are expected in Q4FY26.
Outlook
We maintain our BUY rating on MAHLIFE with a TP of INR 500, factoring in the Residential Business, Integrated Cities & Industrial Clusters (IC&IC), Operations & Maintenance (O&M) segments, as well as the company’s historical land bank.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
